
SC Pembrolizumab in NSCLC May Boost Patient Experience, Efficiency
Enriqueta Felip, MD, PhD, the Universitat Autònoma de Barcelona, Spain, section chief at the Vall d'Hebron University Hospital, head of the Vall d' Hebron Institute of Oncology's thoracic tumors group, discusses how results from the phase 3 …